Free Trial
→ Now I look stupid. Real stupid... (From Porter & Company) (Ad) Buy BTAFF Stock  Free BTAFF Stock Alerts

British American Tobacco (BTAFF) Financials

British American Tobacco logo
$43.31 +2.18 (+5.31%)
As of 04/17/2025 12:08 PM Eastern
Compare
Annual Income Statements for British American Tobacco

Annual Income Statements for British American Tobacco

This table shows British American Tobacco's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 7,006 6,206 51,100 29,028 10,063 9,188 9,648 8,485 -17,854 4,124
Consolidated Net Income / (Loss)		 6,664 5,971 50,869 7,685 0.00 8,965 9,415 8,268 -18,081 3,983
Net Income / (Loss) Continuing Operations		 6,664 5,971 50,869 29,254 10,255 8,965 9,415 8,268 -18,081 3,983
Total Pre-Tax Income 		8,629 7,705 39,888 31,982 10,484 11,843 12,370 11,261 -21,741 4,430
Total Operating Income		 6,716 5,744 8,662 29,685 11,947 13,605 13,816 12,709 -20,071 3,426
Total Gross Profit		 14,842 12,828 19,630 31,116 15,432 29,551 28,758 27,899 28,853 26,834
Total Revenue		 19,312 17,434 26,429 49,526 36,412 35,203 34,673 33,399 34,767 32,388
Operating Revenue		 19,312 17,434 26,429 49,526 36,412 35,203 34,673 33,399 34,767 32,388
Total Cost of Revenue		 4,470 4,606 6,799 18,410 20,980 5,651 5,916 5,500 5,914 5,554
Operating Cost of Revenue		 4,470 4,606 6,799 18,410 20,980 5,651 5,916 5,500 5,914 5,554
Total Operating Expenses		 8,126 7,085 10,968 1,431 2,663 15,946 14,942 15,190 48,924 23,408
Selling, General & Admin Expense		 3,005 2,806 3,619 - - 3,748 3,668 3,589 3,395 3,545
Depreciation Expense		 631 749 1,219 1,322 - 1,980 1,453 1,576 36,463 3,883
Amortization Expense		 - 0.00 0.00 - - 4.10 4.05 6.04 11 13
Other Operating Expenses / (Income)		 4,490 3,530 6,130 108 660 10,214 9,817 10,019 9,055 15,968
Total Other Income / (Expense), net		 1,913 1,962 31,226 2,297 220 -1,762 -1,446 -1,448 -1,669 1,004
Interest Expense		 -91 786 1,478 - - 2,383 2,006 1,982 2,415 1,375
Other Income / (Expense), net		 1,822 2,748 32,704 2,297 216 621 560 534 745 2,379
Income Tax Expense		 1,964 1,735 -10,981 2,728 2,734 2,879 2,955 2,993 -3,660 447
Net Income / (Loss) Attributable to Noncontrolling Interest		 -342 -236 -231 227 192 -224 -234 -217 -227 -141
Weighted Average Basic Shares Outstanding		 230.90 2.50 24.77 2.46B 2.46B 2.80 2.97 3.54 -8.24 1.71
Diluted Earnings per Share		 $230.30 $2.49 $24.69 $2.63 $2.49 $2.79 $2.96 $3.53 ($8.24) $1.70
Weighted Average Diluted Shares Outstanding		 - - 2.46B 2.46B 2.46B 2.46B 2.46B 2.46B 2.46B 2.35B
Weighted Average Basic & Diluted Shares Outstanding		 - - 2.46B 2.46B 2.46B 2.46B 2.46B 2.46B 2.46B 2.35B

Quarterly Income Statements for British American Tobacco

No quarterly income statements for British American Tobacco are available.

Annual Cash Flow Statements for British American Tobacco

This table details how cash moves in and out of British American Tobacco's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 -3,953 -3,745 3,692 629 388 1,551 -806 -4,685 29,354 -2,583
Net Cash From Operating Activities		 50 -83 7,223 2,051 15,416 8,189 13,118 1,370 35,781 3,659
Net Cash From Continuing Operating Activities		 50 -83 7,045 2,051 15,416 8,189 13,167 1,370 35,781 3,659
Net Income / (Loss) Continuing Operations		 0.00 0.00 8,266 0.00 0.00 8,965 9,415 8,268 -18,081 3,983
Consolidated Net Income / (Loss)		 - - 8,266 - 0.00 8,965 9,415 8,268 -18,081 3,983
Depreciation Expense		 631 749 1,219 - - 1,980 1,453 1,576 36,463 3,883
Non-Cash Adjustments To Reconcile Net Income		 -581 -832 116 2,051 15,416 -2,756 5,458 -8,474 17,399 -4,207
Net Cash From Investing Activities		 80 7.40 -25,051 690 633 -157 -1,539 -118 14 285
Net Cash From Continuing Investing Activities		 80 7.40 -24,947 690 633 -157 -1,359 -118 14 285
Purchase of Investments		 -146 -134 -230 408 253 -468 -498 -310 -571 -270
Sale of Property, Plant & Equipment		 159 115 128 48 45 60 42 37 69 182
Sale and/or Maturity of Investments		 66 27 328 213 449 251 235 155 516 374
Net Cash From Financing Activities		 -4,082 -3,669 19,938 5,538 13,101 -6,480 -11,811 -5,936 -6,442 -6,527
Net Cash From Continuing Financing Activities		 -4,082 -3,669 20,774 5,538 13,101 -6,480 -11,764 -5,936 -6,442 -6,527
Payment of Dividends		 -4,082 -3,591 -4,906 5,538 - -6,480 -6,823 -5,936 -6,442 -6,527
Cash Interest Paid		 - - - - 2,121 - - 1,906 2,143 2,132
Cash Interest Received		 94 76 - 66 - 66 - 103 185 234

Quarterly Cash Flow Statements for British American Tobacco

No quarterly cash flow statements for British American Tobacco are available.

Annual Balance Sheets for British American Tobacco

This table presents British American Tobacco's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets		 49,074 190,548 186,437 186,843 188,045 185,443 185,438 151,280 148,873
Total Current Assets		 15,249 19,630 16,122 17,589 18,590 17,289 18,609 18,077 17,898
Cash & Equivalents		 2,719 4,446 3,315 3,347 4,287 3,792 4,162 5,937 6,632
Short-Term Investments		 - 145 - 163 587 683 845 916 825
Accounts Receivable		 5,531 6,496 5,444 5,752 5,082 5,617 5,565 5,023 4,866
Inventories, net		 7,148 7,922 7,681 8,075 8,196 7,127 6,849 6,292 5,780
Plant, Property, & Equipment, net		 4,517 6,595 6,581 7,312 6,910 6,687 0.00 5,840 5,483
Plant, Property & Equipment, gross		 4,517 6,595 6,581 7,312 6,910 6,687 - 5,840 5,483
Total Noncurrent Assets		 17,357 164,324 163,140 161,843 162,514 161,537 162,139 127,271 125,288
Long-Term Investments		 - 2,130 2,213 2,465 2,453 2,630 2,440 2,510 2,381
Intangible Assets		 14,951 159,115 157,990 157,402 157,525 156,094 155,884 121,775 118,043
Noncurrent Deferred & Refundable Income Taxes		 623 450 533 562 729 983 1,004 1,380 3,306
Employee Benefit Assets		 561 1,517 1,461 - - 1,239 1,208 1,218 1,173
Other Noncurrent Operating Assets		 1,198 1,105 936 1,410 1,807 574 678 370 371
Other Noncurrent Nonoperating Assets		 23 6.75 6.37 3.98 - 18 926 18 14
Total Liabilities & Shareholders' Equity		 49,074 355,006 186,437 186,843 188,045 185,443 185,438 151,280 148,873
Total Liabilities		 38,702 144,106 102,752 102,015 100,881 96,726 95,521 85,973 88,384
Total Current Liabilities		 11,846 50,688 16,632 15,404 21,138 15,865 16,148 15,266 15,451
Accounts Payable		 10,333 13,463 14,888 14,259 13,238 14,255 13,759 13,499 12,815
Current Deferred & Payable Income Tax Liabilities		 688 973 1,087 905 - 1,187 1,267 1,264 2,105
Other Current Liabilities		 824 36,252 657 240 1,196 424 1,122 503 531
Total Noncurrent Liabilities		 26,856 93,418 86,120 86,611 80,928 80,861 79,372 70,707 72,934
Long-Term Debt		 24,054 66,802 60,526 60,114 54,529 55,813 54,134 52,775 48,375
Noncurrent Deferred & Payable Income Tax Liabilities		 804 23,139 22,646 22,593 22,280 22,224 22,255 15,536 14,623
Noncurrent Employee Benefit Liabilities		 1,019 2,460 2,121 2,503 2,081 1,673 1,146 1,123 1,027
Other Noncurrent Operating Liabilities		 978 1,017 827 1,402 2,038 1,152 1,837 1,273 8,909
Total Equity & Noncontrolling Interests		 10,372 210,900 83,685 85,017 58,639 88,717 89,756 65,307 60,489
Total Preferred & Common Equity		 10,095 210,600 83,374 84,675 85,593 88,312 89,343 64,838 60,048
Total Common Equity		 10,095 210,600 83,374 84,675 58,254 88,312 89,343 64,838 60,048
Common Stock		 626 829 782 814 839 829 742 782 732
Retained Earnings		 4,110 49,895 49,121 53,313 57,416 59,686 53,237 31,260 27,058
Other Equity Adjustments		 5,360 159,875 33,471 30,548 - 27,797 35,365 32,795 32,258
Noncontrolling Interest		 276 300 311 342 385 405 413 469 441

Quarterly Balance Sheets for British American Tobacco

This table presents British American Tobacco's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q4 2023 Q4 2024
Total Assets		 185,438 151,280 148,873
Total Current Assets		 18,609 18,077 17,898
Cash & Equivalents		 4,162 5,937 6,632
Short-Term Investments		 845 916 825
Accounts Receivable		 5,565 5,023 4,866
Inventories, net		 6,849 6,292 5,780
Plant, Property, & Equipment, net		 0.00 5,840 5,483
Plant, Property & Equipment, gross		 - 5,840 5,483
Total Noncurrent Assets		 162,139 127,271 125,288
Long-Term Investments		 2,440 2,510 2,381
Intangible Assets		 155,884 121,775 118,043
Noncurrent Deferred & Refundable Income Taxes		 1,004 1,380 3,306
Employee Benefit Assets		 1,208 1,218 1,173
Other Noncurrent Operating Assets		 678 370 371
Other Noncurrent Nonoperating Assets		 926 18 14
Total Liabilities & Shareholders' Equity		 185,438 151,280 148,873
Total Liabilities		 95,521 85,973 88,384
Total Current Liabilities		 16,148 15,266 15,451
Accounts Payable		 13,759 13,499 12,815
Current Deferred & Payable Income Tax Liabilities		 1,267 1,264 2,105
Other Current Liabilities		 1,122 503 531
Total Noncurrent Liabilities		 79,372 70,707 72,934
Long-Term Debt		 54,134 52,775 48,375
Noncurrent Deferred & Payable Income Tax Liabilities		 22,255 15,536 14,623
Noncurrent Employee Benefit Liabilities		 1,146 1,123 1,027
Other Noncurrent Operating Liabilities		 1,837 1,273 8,909
Total Equity & Noncontrolling Interests		 89,756 65,307 60,489
Total Preferred & Common Equity		 89,343 64,838 60,048
Total Common Equity		 89,343 64,838 60,048
Common Stock		 742 782 732
Retained Earnings		 53,237 31,260 27,058
Other Equity Adjustments		 35,365 32,795 32,258
Noncontrolling Interest		 413 469 441

Annual Metrics and Ratios for British American Tobacco

This table displays calculated financial ratios and metrics derived from British American Tobacco's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% -9.72% 51.59% 87.39% -26.48% -3.32% -1.50% -3.68% 4.10% -6.84%
EBITDA Growth		 0.00% 0.79% 360.85% -21.79% -63.48% 33.25% -2.33% -6.38% 15.64% -43.47%
EBIT Growth		 0.00% -0.54% 387.15% -22.68% -61.97% 16.97% 1.05% -7.89% -245.94% 130.04%
NOPAT Growth		 0.00% -14.20% 148.21% 145.81% -67.47% 16.60% 2.11% -11.26% -250.57% 121.92%
Net Income Growth		 0.00% -10.41% 751.99% -84.89% -100.00% 0.00% 5.02% -12.18% -318.69% 122.03%
EPS Growth		 0.00% -10.41% 890.73% -85.60% -5.40% 12.01% 5.99% 19.26% -333.73% 120.67%
Operating Cash Flow Growth		 0.00% -264.98% 8,837.62% -71.60% 651.59% -46.88% 60.19% -89.56% 2,512.65% -89.77%
Free Cash Flow Firm Growth		 0.00% 0.00% -389.86% 93.74% 278.82% 12.87% 32.31% 34.09% -58.38% 81.14%
Invested Capital Growth		 0.00% 0.00% 435.77% 29.93% 0.27% 0.54% -1.52% -5.54% -16.26% -8.91%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 76.85% 73.58% 74.27% 62.83% 42.38% 83.95% 82.94% 83.53% 82.99% 82.85%
EBITDA Margin		 47.47% 53.00% 161.13% 67.25% 33.40% 46.04% 45.65% 44.37% 49.29% 29.91%
Operating Margin		 34.78% 32.94% 32.77% 59.94% 32.81% 38.65% 39.85% 38.05% -57.73% 10.58%
EBIT Margin		 44.21% 48.70% 156.52% 64.58% 33.40% 40.41% 41.46% 39.65% -55.59% 17.92%
Profit (Net Income) Margin		 34.51% 34.25% 192.48% 15.52% 0.00% 25.47% 27.15% 24.76% -52.01% 12.30%
Tax Burden Percent		 77.23% 77.49% 127.53% 24.03% 0.00% 75.69% 76.11% 73.42% 83.17% 89.91%
Interest Burden Percent		 101.07% 90.74% 96.43% 100.00% 86.20% 83.25% 86.05% 85.03% 112.50% 76.32%
Effective Tax Rate		 22.77% 22.51% -27.53% 8.53% 26.07% 24.31% 23.89% 26.58% 0.00% 10.09%
Return on Invested Capital (ROIC)		 0.00% 44.77% 17.48% 22.17% 6.37% 7.40% 7.59% 6.98% -11.78% 2.97%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 76.74% -66.47% 100.57% -9.91% 5.42% 5.90% 4.59% -21.44% 5.17%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 70.36% 28.50% -16.96% -6.37% 5.08% 5.18% 2.28% -11.54% 3.37%
Return on Equity (ROE)		 0.00% 115.13% 45.98% 5.22% 0.00% 12.48% 12.78% 9.27% -23.32% 6.33%
Cash Return on Invested Capital (CROIC)		 0.00% -155.23% -119.60% -3.86% 6.10% 6.86% 9.12% 12.68% 5.91% 12.30%
Operating Return on Assets (OROA)		 0.00% 17.30% 34.53% 16.97% 6.52% 7.59% 7.70% 7.14% -11.48% 3.87%
Return on Assets (ROA)		 0.00% 12.17% 42.46% 4.08% 0.00% 4.78% 5.04% 4.46% -10.74% 2.65%
Return on Common Equity (ROCE)		 0.00% 112.06% 45.86% 5.21% 0.00% 12.42% 12.71% 9.22% -23.19% 6.29%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 59.14% 24.15% 9.22% 0.00% 10.47% 10.66% 9.25% -27.89% 6.63%
Net Operating Profit after Tax (NOPAT)		 5,187 4,450 11,047 27,153 8,832 10,298 10,515 9,331 -14,050 3,080
NOPAT Margin		 26.86% 25.53% 41.80% 54.83% 24.26% 29.25% 30.33% 27.94% -40.41% 9.51%
Net Nonoperating Expense Percent (NNEP)		 0.00% -31.97% 83.95% -78.39% 16.28% 1.98% 1.70% 2.40% 9.66% -2.20%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 6.48% -11.90% 2.83%
Cost of Revenue to Revenue		 23.15% 26.42% 25.73% 37.17% 57.62% 16.05% 17.06% 16.47% 17.01% 17.15%
SG&A Expenses to Revenue		 15.56% 16.09% 13.69% 0.00% 0.00% 10.65% 10.58% 10.75% 9.76% 10.94%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 42.08% 40.64% 41.50% 2.89% 7.31% 45.30% 43.09% 45.48% 140.72% 72.27%
Earnings before Interest and Taxes (EBIT)		 8,537 8,491 41,366 31,982 12,163 14,227 14,376 13,242 -19,326 5,805
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 9,168 9,240 42,584 33,304 12,163 16,207 15,829 14,818 17,137 9,687
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.49 0.64 0.90 1.25 0.89 0.90 0.99 1.49
Price to Tangible Book Value (P/TBV)		 0.00 0.00 2.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 3.93 1.08 2.10 2.07 2.27 2.40 1.85 2.75
Price to Earnings (P/E)		 0.00 0.00 2.03 1.85 7.61 7.94 8.16 9.45 0.00 21.63
Dividend Yield		 6.92% 6.26% 6.84% 11.63% 8.29% 11.43% 9.19% 8.09% 11.10% 0.00%
Earnings Yield		 0.00% 0.00% 49.22% 54.04% 13.14% 12.59% 12.26% 10.59% 0.00% 4.62%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 1.54 0.79 0.94 0.90 0.93 0.98 0.99 1.29
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 6.21 2.20 3.60 3.58 3.69 3.81 3.11 3.96
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 3.86 3.27 10.77 7.78 8.07 8.59 6.31 13.23
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 3.97 3.41 10.77 8.86 8.89 9.61 0.00 22.09
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 14.87 4.02 14.84 12.24 12.16 13.64 0.00 41.62
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 22.73 53.15 8.50 15.40 9.74 92.92 3.02 35.04
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 15.49 13.21 10.12 7.51 15.34 10.04
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 2.32 0.32 0.72 0.71 1.02 0.63 0.60 0.81 0.80
Long-Term Debt to Equity		 0.00 2.32 0.32 0.72 0.71 0.93 0.63 0.60 0.81 0.80
Financial Leverage		 0.00 0.92 -0.43 -0.17 0.64 0.94 0.88 0.50 0.54 0.65
Leverage Ratio		 0.00 4.73 1.08 1.28 2.21 2.61 2.53 2.08 2.17 2.39
Compound Leverage Factor		 0.00 4.29 1.04 1.28 1.91 2.17 2.18 1.77 2.44 1.82
Debt to Total Capital		 0.00% 69.87% 24.06% 41.97% 41.42% 50.59% 38.62% 37.62% 44.69% 44.44%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 4.65% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 69.87% 24.06% 41.97% 41.42% 45.94% 38.62% 37.62% 44.69% 44.44%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.80% 0.11% 0.22% 0.24% 0.32% 0.28% 0.29% 0.40% 0.40%
Common Equity to Total Capital		 0.00% 29.33% 75.84% 57.81% 58.34% 49.08% 61.10% 62.09% 54.91% 55.16%
Debt to EBITDA		 0.00 2.60 1.57 1.82 4.94 3.71 3.53 3.65 3.08 4.99
Net Debt to EBITDA		 0.00 2.31 1.41 1.65 4.45 3.25 3.08 3.15 2.53 3.98
Long-Term Debt to EBITDA		 0.00 2.60 1.57 1.82 4.94 3.36 3.53 3.65 3.08 4.99
Debt to NOPAT		 0.00 5.40 6.05 2.23 6.81 5.83 5.31 5.80 -3.76 15.71
Net Debt to NOPAT		 0.00 4.79 5.44 2.03 6.13 5.12 4.63 5.00 -3.09 12.51
Long-Term Debt to NOPAT		 0.00 5.40 6.05 2.23 6.81 5.30 5.31 5.80 -3.76 15.71
Altman Z-Score		 0.00 0.00 1.46 1.51 1.27 1.28 1.39 1.34 0.57 1.23
Noncontrolling Interest Sharing Ratio		 0.00% 2.66% 0.26% 0.21% 0.39% 0.51% 0.54% 0.46% 0.57% 0.72%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.00 1.29 0.39 0.97 1.14 0.88 1.09 1.15 1.18 1.16
Quick Ratio		 0.00 0.70 0.22 0.53 0.60 0.47 0.64 0.65 0.78 0.80
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -15,431 -75,589 -4,730 8,459 9,547 12,632 16,938 7,050 12,769
Operating Cash Flow to CapEx		 0.00% 0.00% 605.55% 0.00% 0.00% 0.00% 1,360.92% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 -19.63 -51.15 0.00 0.00 4.01 6.30 8.55 2.92 9.29
Operating Cash Flow to Interest Expense		 0.00 -0.11 4.89 0.00 0.00 3.44 6.54 0.69 14.82 2.66
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.04 4.08 0.00 0.00 3.46 6.06 0.71 14.85 2.79
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.36 0.22 0.26 0.20 0.19 0.19 0.18 0.21 0.22
Accounts Receivable Turnover		 0.00 3.15 4.39 8.30 6.50 6.50 6.48 5.97 6.57 6.55
Inventory Turnover		 0.00 0.64 0.90 2.36 2.66 0.69 0.77 0.79 0.90 0.92
Fixed Asset Turnover		 0.00 3.86 4.76 7.52 5.24 4.95 5.10 0.00 0.00 5.72
Accounts Payable Turnover		 0.00 0.45 0.57 1.30 1.44 0.41 0.43 0.39 0.43 0.42
Days Sales Outstanding (DSO)		 0.00 115.80 83.06 44.00 56.11 56.17 56.31 61.10 55.58 55.72
Days Inventory Outstanding (DIO)		 0.00 566.42 404.49 154.67 137.06 525.44 472.69 463.74 405.53 396.66
Days Payable Outstanding (DPO)		 0.00 818.88 638.75 281.04 253.54 887.97 848.15 929.58 841.15 864.60
Cash Conversion Cycle (CCC)		 0.00 -136.66 -151.20 -82.37 -60.37 -306.37 -319.14 -404.73 -380.04 -412.22
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 19,881 106,516 138,400 138,773 139,524 137,407 129,800 108,700 99,011
Invested Capital Turnover		 0.00 1.75 0.42 0.40 0.26 0.25 0.25 0.25 0.29 0.31
Increase / (Decrease) in Invested Capital		 0.00 19,881 86,635 31,884 373 751 -2,117 -7,607 -21,100 -9,689
Enterprise Value (EV)		 0.00 0.00 164,210 109,024 131,043 126,094 127,816 127,260 108,139 128,201
Market Capitalization		 0.00 0.00 103,829 53,715 76,562 72,988 78,703 80,160 64,258 89,224
Book Value per Share		 $0.00 $4,034,916,346.92 $8,500,835,485.99 $33.94 $34.47 $0.00 $29,744,560,458.07 $25,222,525,718.48 $26.39 $24.44
Tangible Book Value per Share		 $0.00 ($1,940,527,478.02) $2,078,191,639.62 ($30.38) ($29.61) $0.00 ($22,829,959,582.35) ($18,785,118,542.15) ($23.17) ($23.61)
Total Capital		 0.00 34,426 277,701 144,211 145,131 118,687 144,530 143,890 118,082 108,864
Total Debt		 0.00 24,054 66,802 60,526 60,114 60,048 55,813 54,134 52,775 48,375
Total Long-Term Debt		 0.00 24,054 66,802 60,526 60,114 54,529 55,813 54,134 52,775 48,375
Net Debt		 0.00 21,335 60,081 54,998 54,139 52,721 48,708 46,687 43,412 38,536
Capital Expenditures (CapEx)		 -159 -115 1,193 -48 -45 -60 964 -37 -69 -182
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 684 -35,649 -3,824 -1,325 -1,904 -3,051 -2,546 -4,042 -5,011
Debt-free Net Working Capital (DFNWC)		 0.00 3,403 -31,058 -510 2,185 2,970 1,424 2,461 2,811 2,447
Net Working Capital (NWC)		 0.00 3,403 -31,058 -510 2,185 -2,548 1,424 2,461 2,811 2,447
Net Nonoperating Expense (NNE)		 -1,477 -1,520 -39,823 19,469 8,832 1,334 1,100 1,063 4,031 -903
Net Nonoperating Obligations (NNO)		 0.00 9,509 -104,383 54,715 53,756 80,884 48,690 40,044 43,394 38,522
Total Depreciation and Amortization (D&A)		 631 749 1,219 1,322 0.00 1,980 1,453 1,576 36,463 3,883
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 3.92% -134.89% -7.72% -3.64% -5.41% -8.80% -7.62% -11.63% -15.47%
Debt-free Net Working Capital to Revenue		 0.00% 19.52% -117.52% -1.03% 6.00% 8.44% 4.11% 7.37% 8.09% 7.55%
Net Working Capital to Revenue		 0.00% 19.52% -117.52% -1.03% 6.00% -7.24% 4.11% 7.37% 8.09% 7.55%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 1.84K 3.00 2.00 0.00 0.00 3.00 -6.00 2.00
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $1,830.00 $2.63 $2.49 $0.00 $0.00 $2.92 ($6.47) $1.70
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 2.46B 2.46B 2,456.52T 0.00 0.00 2.46B 2.46B 2.35B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 2.46B 2.46B 2,456.52T 0.00 0.00 2.46B 2.46B 2.35B
Normalized Net Operating Profit after Tax (NOPAT)		 5,187 4,450 6,063 27,153 10,313 10,298 10,515 9,331 -14,050 3,080
Normalized NOPAT Margin		 26.86% 25.53% 22.94% 54.83% 28.32% 29.25% 30.33% 27.94% -40.41% 9.51%
Pre Tax Income Margin		 44.68% 44.20% 150.93% 64.58% 28.79% 33.64% 35.68% 33.72% -62.53% 13.68%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 10.80 27.99 0.00 0.00 5.97 7.17 6.68 -8.00 4.22
NOPAT to Interest Expense		 0.00 5.66 7.47 0.00 0.00 4.32 5.24 4.71 -5.82 2.24
EBIT Less CapEx to Interest Expense		 0.00 10.95 27.18 0.00 0.00 5.99 6.69 6.70 -7.97 4.35
NOPAT Less CapEx to Interest Expense		 0.00 5.81 6.67 0.00 0.00 4.35 4.76 4.73 -5.79 2.37
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 61.26% 60.14% 9.65% -72.07% 0.00% 72.29% 72.47% 71.79% -35.63% 163.88%
Augmented Payout Ratio		 61.26% 60.14% 9.65% -72.07% 0.00% 72.29% 72.47% 71.79% -35.63% 163.88%

Quarterly Metrics and Ratios for British American Tobacco

No quarterly metrics and ratios for British American Tobacco are available.

Frequently Asked Questions About British American Tobacco's Financials

When does British American Tobacco's fiscal year end?

According to the most recent income statement we have on file, British American Tobacco's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has British American Tobacco's net income changed over the last 9 years?

British American Tobacco's net income appears to be on a downward trend, with a most recent value of $3.98 billion in 2024, falling from $6.66 billion in 2015. The previous period was -$18.08 billion in 2023.

What is British American Tobacco's operating income?
British American Tobacco's total operating income in 2024 was $3.43 billion, based on the following breakdown:
  • Total Gross Profit: $26.83 billion
  • Total Operating Expenses: $23.41 billion
How has British American Tobacco revenue changed over the last 9 years?

Over the last 9 years, British American Tobacco's total revenue changed from $19.31 billion in 2015 to $32.39 billion in 2024, a change of 67.7%.

How much debt does British American Tobacco have?

British American Tobacco's total liabilities were at $88.38 billion at the end of 2024, a 2.8% increase from 2023, and a 128.4% increase since 2016.

How much cash does British American Tobacco have?

In the past 8 years, British American Tobacco's cash and equivalents has ranged from $2.72 billion in 2016 to $6.63 billion in 2024, and is currently $6.63 billion as of their latest financial filing in 2024.

How has British American Tobacco's book value per share changed over the last 9 years?

Over the last 9 years, British American Tobacco's book value per share changed from 0.00 in 2015 to 24.44 in 2024, a change of 2,444.1%.


Related Companies

This page (OTCMKTS:BTAFF) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
The Crypto Market is About to Change Lives
I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...
Crypto 101 Media | Sponsored